Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Unknown 3Terminated 1

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Other neoplasm 1Gastrointestinal 1

Conditions

Prediabetic State 1Neoplasms 1Diabetes Mellitus, Type 2 1Diabetes Mellitus, Type 1 1Diabetes Mellitus 1Colorectal Neoplasms 1Bone Metastases 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Continuous Glucose Monitoring × Clear all
NCT05998460 2023-12-21

GET CHARGED

Georgetown University

Phase NA Unknown
100 enrolled

Prediabetic State

NCT06011473 2023-08-31

CGM-CRC

Medical University of Gdansk

Phase NA Unknown
40 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT02715856 2022-10-13

Telemonitoring After Surgery to Preserve Limb Function in Optimizing Mobility in Cancer Survivors With Skeletal Metastases

M.D. Anderson Cancer Center

Phase NA Terminated
70 enrolled 5 charts
Other neoplasm

Bone Metastases

NCT04942756 2021-07-22

GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.

Antea Foundation

Phase NA Unknown
118 enrolled

Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡